Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 127

1.

Characterization of a novel rat gene RTAP2a, screened by cross-reactive SEREX, restrictedly expressed in testis.

Yang H, Wang C, Wang R, Deng H, Ding Z, Yang J, Lu Y, Li J, Zhang P, Mao Y, Kan B, Wei L, Peng F, Wei Y.

J Biosci Bioeng. 2009 Jun;107(6):589-95. doi: 10.1016/j.jbiosc.2009.02.005.

PMID:
19447332
[PubMed - indexed for MEDLINE]
2.

Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene.

Jäger D, Stockert E, Scanlan MJ, Güre AO, Jäger E, Knuth A, Old LJ, Chen YT.

Cancer Res. 1999 Dec 15;59(24):6197-204.

PMID:
10626813
[PubMed - indexed for MEDLINE]
Free Article
3.

Identification and characterization of a novel cancer/testis antigen gene CAGE.

Cho B, Lim Y, Lee DY, Park SY, Lee H, Kim WH, Yang H, Bang YJ, Jeoung DI.

Biochem Biophys Res Commun. 2002 Apr 5;292(3):715-26.

PMID:
11922625
[PubMed - indexed for MEDLINE]
4.

Identification and characterization of a novel cancer/testis antigen gene CAGE-1.

Park S, Lim Y, Lee D, Cho B, Bang YJ, Sung S, Kim HY, Kim DK, Lee YS, Song Y, Jeoung DI.

Biochim Biophys Acta. 2003 Jan 27;1625(2):173-82.

PMID:
12531476
[PubMed - indexed for MEDLINE]
5.

The MMA1 gene family of cancer-testis antigens has multiple alternative splice variants: characterization of their expression profile, the genomic organization, and transcript properties.

de Wit NJ, Cornelissen IM, Diepstra JH, Weidle UH, Ruiter DJ, van Muijen GN.

Genes Chromosomes Cancer. 2005 Jan;42(1):10-21.

PMID:
15472897
[PubMed - indexed for MEDLINE]
6.

A novel cancer testis antigen that is frequently expressed in pancreatic, lung, and endometrial cancers.

Okada T, Akada M, Fujita T, Iwata T, Goto Y, Kido K, Okada T, Matsuzaki Y, Kobayashi K, Matsuno S, Sunamura M, Kawakami Y.

Clin Cancer Res. 2006 Jan 1;12(1):191-7.

PMID:
16397042
[PubMed - indexed for MEDLINE]
Free Article
7.

Identification of a novel prostate cancer-associated tumor antigen.

Miles AK, Rogers A, Li G, Seth R, Powe D, McArdle SE, McCulloch TA, Bishop MC, Rees RC.

Prostate. 2007 Feb 15;67(3):274-87.

PMID:
17192878
[PubMed - indexed for MEDLINE]
8.

N- and C-terminal isoforms of Arg quantified by real-time PCR are specifically expressed in human normal and neoplastic cells, in neoplastic cell lines, and in HL-60 cell differentiation.

Perego RA, Corizzato M, Bianchi C, Eroini B, Bosari S.

Mol Carcinog. 2005 Apr;42(4):229-39.

PMID:
15765532
[PubMed - indexed for MEDLINE]
9.

Genome-wide detection of testis- and testicular cancer-specific alternative splicing.

He C, Zuo Z, Chen H, Zhang L, Zhou F, Cheng H, Zhou R.

Carcinogenesis. 2007 Dec;28(12):2484-90. Epub 2007 Aug 27.

PMID:
17724370
[PubMed - indexed for MEDLINE]
Free Article
10.

Characterization of a SEPT9 interacting protein, SEPT14, a novel testis-specific septin.

Peterson EA, Kalikin LM, Steels JD, Estey MP, Trimble WS, Petty EM.

Mamm Genome. 2007 Nov;18(11):796-807. Epub 2007 Oct 6.

PMID:
17922164
[PubMed - indexed for MEDLINE]
11.

Identification of CCDC62-2 as a novel cancer/testis antigen and its immunogenicity.

Domae S, Nakamura Y, Nakamura Y, Uenaka A, Wada H, Nakata M, Oka M, Kishimoto K, Tsukamoto G, Yoshihama Y, Matsuoka J, Gochi A, Kohno S, Saika T, Sasaki A, Nakayama E, Ono T.

Int J Cancer. 2009 May 15;124(10):2347-52. doi: 10.1002/ijc.24220.

PMID:
19165854
[PubMed - indexed for MEDLINE]
12.

Identification and molecular characterization of five novel kallikrein gene 13 (KLK13; KLK-L4) splice variants: differential expression in the human testis and testicular cancer.

Chang A, Yousef GM, Jung K, Rajpert-De Meyts E, Diamandis EP.

Anticancer Res. 2001 Sep-Oct;21(5):3147-52.

PMID:
11848466
[PubMed - indexed for MEDLINE]
13.

[Serological screening of xenogeneic antigens from rat testis].

Peng F, Tian L, Deng HX, Li Y, Yang HS, Kan B, Zhao X, Liao J, Wei YQ.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2004 May;35(3):305-8. Chinese.

PMID:
15181820
[PubMed - indexed for MEDLINE]
14.

Cancer/testis (CT) antigens: potential targets for immunotherapy.

Caballero OL, Chen YT.

Cancer Sci. 2009 Nov;100(11):2014-21. doi: 10.1111/j.1349-7006.2009.01303.x. Epub 2009 Aug 1. Review.

PMID:
19719775
[PubMed - indexed for MEDLINE]
15.

Identification of FAM46D as a novel cancer/testis antigen using EST data and serological analysis.

Bettoni F, Filho FC, Grosso DM, Galante PA, Parmigiani RB, Geraldo MV, Henrique-Silva F, Oba-Shinjo SM, Marie SK, Soares FA, Brentani HP, Simpson AJ, de Souza SJ, Camargo AA.

Genomics. 2009 Sep;94(3):153-60. doi: 10.1016/j.ygeno.2009.06.001. Epub 2009 Jun 18.

PMID:
19540335
[PubMed - indexed for MEDLINE]
Free Article
16.

Serological identification and bioinformatics analysis of immunogenic antigens in multiple myeloma.

Zhou FL, Zhang WG, Chen G, Zhao WH, Cao XM, Chen YX, Tian W, Liu J, Liu SH.

Cancer Immunol Immunother. 2006 Aug;55(8):910-7. Epub 2005 Sep 29.

PMID:
16193335
[PubMed - indexed for MEDLINE]
17.

Infrequent and low expression of cancer-testis antigens located on the X chromosome in colorectal cancer: implications for immunotherapy in South African populations.

Dakshinamurthy AG, Ramesar R, Goldberg P, Blackburn JM.

Biotechnol J. 2008 Nov;3(11):1417-23. doi: 10.1002/biot.200800144.

PMID:
18956367
[PubMed - indexed for MEDLINE]
18.
19.

Isolation of LEM domain-containing 1, a novel testis-specific gene expressed in colorectal cancers.

Yuki D, Lin YM, Fujii Y, Nakamura Y, Furukawa Y.

Oncol Rep. 2004 Aug;12(2):275-80.

PMID:
15254688
[PubMed - indexed for MEDLINE]
20.

Efficient identification of a novel cancer/testis antigen for immunotherapy using three-step microarray analysis.

Yokoe T, Tanaka F, Mimori K, Inoue H, Ohmachi T, Kusunoki M, Mori M.

Cancer Res. 2008 Feb 15;68(4):1074-82. doi: 10.1158/0008-5472.CAN-07-0964.

PMID:
18281482
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk